ConductScience.org, home

Paper590303

Pharmacokinetics of atenolol in patients with renal impairment.

Sassard J and 4 others. Eur J Clin Pharmacol, 1977. Cited by 44 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pharmacokinetics of atenolol in patients with renal impairment. Papers, record 590303. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/590303

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics of atenolol in patients with renal impairment.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
2.69
iCite
Revised in PubMed
2026-10-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sassard JJ
2Pozet NN
3McAinsh JJ
4Legheand JJ
5Zech PP

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtenololMajor topic
Kidney DiseasesMajor topic
PropanolaminesMajor topic
Blood Pressure
Heart Rate
Humans
Hypertension
Kinetics
Renin
Time Factors

Source PubMed

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,031,656Pharmacodynamics of propranolol in renal failure.Br Med J1972https://conductscience.org/library/papers/5031656PubMed
210,125Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.Clin Pharmacol Ther1976https://conductscience.org/library/papers/10125PubMed
35,021,493Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.Am J Cardiol1972https://conductscience.org/library/papers/5021493PubMed
4236,841Dissociation between renin and arterial pressure responses to beta-adrenergic blockade in human essential hypertension.Circ Res1975https://conductscience.org/library/papers/236841PubMed
54,405,104Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man.Clin Pharmacol Ther1973https://conductscience.org/library/papers/4405104PubMed
64,426,144Pharmacokinetics of oral propranolol in chronic renal disease.Clin Pharmacol Ther1974https://conductscience.org/library/papers/4426144PubMed
71,093,756Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension.Circ Res1975https://conductscience.org/library/papers/1093756PubMed
8242,209Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.Am J Cardiol1975https://conductscience.org/library/papers/242209PubMed
9241,876[Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].Klin Wochenschr1975https://conductscience.org/library/papers/241876PubMed
104,456,598[Effects of combined treatment with hydrochlorothiazide and oxprenolol on arterial pressure and activity of plasma renin. Preliminary results].Schweiz Med Wochenschr1974https://conductscience.org/library/papers/4456598PubMed
114,730,841The pharmacokinetics of unchanged pindolol in patients with impaired renal function.Br J Pharmacol1973https://conductscience.org/library/papers/4730841PubMed
124,853,603Pharmacokinetics of practolol in renal failure.Eur J Clin Pharmacol1974https://conductscience.org/library/papers/4853603PubMed
134,448,555Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response.Int J Clin Pharmacol1974https://conductscience.org/library/papers/4448555PubMed
144,349,612[Rapid method for radio-immunochemical determination of plasma renin activity].Rev Eur Etud Clin Biol1972https://conductscience.org/library/papers/4349612PubMed
151,233,259Relationship between renal function and elimination kinetics of pindolol in man.Eur J Clin Pharmacol1975https://conductscience.org/library/papers/1233259PubMed
16324,694Relationship between blood level of atenolol and pharmacologic effect.Clin Pharmacol Ther1977https://conductscience.org/library/papers/324694PubMed
17973,955Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.Br J Clin Pharmacol1976https://conductscience.org/library/papers/973955PubMed
18237,092The gas chromatographic determination of atenolol in biological samples.J Pharm Pharmacol1975https://conductscience.org/library/papers/237092PubMed
195,084,985Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.N Engl J Med1972https://conductscience.org/library/papers/5084985PubMed
201,249,191A kinetic study of plasma renin and aldosterone during changes of posture in man.J Clin Endocrinol Metab1976https://conductscience.org/library/papers/1249191PubMed

See all 25 references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
34,112,223Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.Crit Care2021https://conductscience.org/library/papers/34112223PubMed
19,248,645In-vitro relationship between protein-binding and free drug concentrations of a water-soluble selective beta-adrenoreceptor antagonist (atenolol) and its interaction with arsenic.J Health Popul Nutr2009https://conductscience.org/library/papers/19248645PubMed
7,461,026Pharmacokinetics of atenolol in relation to renal function.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7461026PubMed
7,439,252Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiency.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7439252PubMed
7,418,712Pharmacokinetics of atenolol in hypertensive subjects with and without co-administration of chlorthalidone.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7418712PubMed
7,378,254Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7378254PubMed
7,002,567Time-course of the anti-hypertensive action of atenolol: comparison of response to first dose and to maintained oral administration.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7002567PubMed
6,992,822Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6992822PubMed
6,814,675Renal artery thrombosis caused by antihypertensive treatment.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6814675PubMed
6,749,509Clinical pharmacokinetics of atenolol--a review.Eur J Drug Metab Pharmacokinet1982https://conductscience.org/library/papers/6749509PubMed
6,105,934
Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.
Clin Pharmacokinet1980https://conductscience.org/library/papers/6105934PubMed
6,102,500Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function.Clin Pharmacokinet1980https://conductscience.org/library/papers/6102500PubMed
3,609,072Pharmacokinetic and pharmacodynamic modelling of atenolol in rabbits maintained on continuous peritoneal dialysis.Eur J Drug Metab Pharmacokinet1987https://conductscience.org/library/papers/3609072PubMed
3,582,468A comparative study of the pharmacokinetics and pharmacodynamics of atenolol, hydrochlorothiazide and amiloride in normal young and elderly subjects and elderly hypertensive patients.Eur J Clin Pharmacol1987https://conductscience.org/library/papers/3582468PubMed
3,358,894The effect of ageing on the disposition of nifedipine and atenolol.Br J Clin Pharmacol1988https://conductscience.org/library/papers/3358894PubMed
2,887,325Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease.Clin Pharmacokinet1987https://conductscience.org/library/papers/2887325PubMed
1,888,640The effect of infinitesimal drug dilutions on the pharmacokinetics of nalidixic acid and atenolol.Br J Clin Pharmacol1991https://conductscience.org/library/papers/1888640PubMed
658,112Studies on the pharmacokinetics and pharmacodynamics of atenolol in man.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/658112PubMed
465,278Pharmacokinetics, pharmacology of atenolol and effect of renal disease.Br J Clin Pharmacol1979https://conductscience.org/library/papers/465278PubMed
38,096Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.Drugs1979https://conductscience.org/library/papers/38096PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5,972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/590303

GET https://conductscience.org/api/papers/v1/590303/references?page=2